We Can’t Neglect Cancer During COVID-19 | Guest: Dr. Pat Basu | Ep 67

While it’s important to fight the COVID-19 pandemic, we can’t forget about the other health care issues people are dealing with. Pat Basu is a medical doctor and the CEO of Cancer Treatment Centers of America, an organization dedicated to helping cancer patients for over 35 years. Together with Matt Kibbe, he talks about the dangers of delaying treatments for cancer patients, as some governors have ordered in states across the country.

Subscribe to Kibbe on Liberty everywhere you get podcasts.
#mattkibbe #patbasu #ctca #kibbeonliberty

Read more on COVID-19 from Free the People: https://freethepeople.org/covid-19

Watch Kibbe on Liberty on BlazeTV: https://blazetv.com/kibbe
Follow Kibbe on Liberty on Facebook: https://facebook.com/KibbeBlazeTV
Follow Free the People on YouTube: https://youtube.com/freethepeople
Follow Free the People on Twitter: https://twitter.com/freethepeople
Follow Free the People on Instagram: https://instagram.com/freethepeople
Follow Free the People on Facebook: https://facebook.com/freethepeople
Visit Free the People's Website: https://freethepeople.org

Kibbe on Liberty is a weekly podcast with libertarian author, economist, and community organizer Matt Kibbe. As the president of Free the People, Kibbe has decades of experience in the libertarian political sphere, but in these troubled times he believes that open dialogue is needed to bring people together. This means being willing to talk, and especially listen, to those with whom we might not always agree, trying to understand perspectives that might otherwise be foreign to us.

Kibbe on Liberty's growing roster of guests includes politicians, economists, comedians, writers, radio personalities, activists, journalists, and even a magician or two—with topics of conversation ranging from current affairs to craft beer and the Grateful Dead. So grab a cold one, and settle in for the next hour of Kibbe on Liberty, mostly honest conversations with mostly interesting people.